SUDEEPPHRM — Sudeep Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹74.94bn
- IN₹75.79bn
- IN₹4.97bn
Annual cashflow statement for Sudeep Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 685 | 860 | 1,748 | 1,828 |
| Depreciation | ||||
| Non-Cash Items | 10.8 | 99.9 | 44.5 | 48.6 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -770 | -555 | -1,226 | -1,496 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -26.4 | 484 | 657 | 487 |
| Capital Expenditures | -578 | -472 | -525 | -642 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 193 | -28.6 | 31.8 | -145 |
| Sale of Fixed Assets | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -384 | -500 | -493 | -788 |
| Financing Cash Flow Items | -18.2 | -46.5 | -37.6 | -54.2 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 506 | -97.8 | -127 | 527 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 95.2 | -112 | 36.7 | 228 |